Valuation : IXICO plc

Market Cap 16.35M 22.14M 19.05M 17.87M 30.52M 2.09B 30.76M 211M 82.35M 1.07B 83.13M 81.32M 3.44B P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 6.15M 8.33M 7.17M 6.73M 11.49M 787M 11.58M 79.56M 30.99M 402M 31.28M 30.6M 1.3B EV / Sales 2026 *
0.77x
EV / Sales 2027 * 1.14x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 week-3.23%
Current month-3.23%
1 month-6.25%
3 months-13.29%
6 months-3.23%
Current year-36.17%
1 week 7
Extreme 7
8
1 month 7
Extreme 7
8.5
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.23%-36.71%-63.05% 22.09M
-0.24%-1.09%+2.00%+18.17% 50.14B
+0.78%-4.65%+430.22%+501.63% 44.85B
+2.95%+3.52%+47.12%+21.08% 43.43B
+0.25%-2.63%+7.86%+73.60% 41.14B
+0.43%-2.20%+14.55%+49.08% 32.92B
+1.43%+8.73% - - 17.56B
+0.06%-2.97%+23.31%+116.96% 16.55B
+0.93%+0.63%+16.86%+29.70% 14.65B
+0.54%-1.03%+80.71%+39.94% 13.93B
Average +0.71%-0.85%+65.10%+87.46% 27.52B
Weighted average by Cap. +0.81%-0.96%+93.16%+123.79%

Financials

2026 *2027 *
Net sales 8M 10.83M 9.32M 8.74M 14.93M 1.02B 15.05M 103M 40.28M 523M 40.67M 39.78M 1.68B 9M 12.18M 10.48M 9.84M 16.8M 1.15B 16.93M 116M 45.32M 589M 45.75M 44.75M 1.9B
Net income -2.14M -2.9M -2.5M -2.34M -4M -274M -4.03M -27.71M -10.79M -140M -10.89M -10.66M -451M -2.8M -3.79M -3.26M -3.06M -5.23M -358M -5.27M -36.22M -14.1M -183M -14.24M -13.93M -590M
Net Debt -10.2M -13.81M -11.88M -11.15M -19.04M -1.31B -19.19M -132M -51.36M -667M -51.85M -50.72M -2.15B -6.1M -8.26M -7.1M -6.67M -11.39M -781M -11.48M -78.87M -30.72M -399M -31.01M -30.33M -1.28B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-09-03 GBX 7.500 0.00% 57,826
26-09-02 GBX 7.500 0.00% 20,000
26-09-01 GBX 7.500 -3.23% 70,164
26-08-28 GBX 7.750 0.00% 0
26-08-27 GBX 7.750 0.00% 60,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise